Role of lipid-based excipients and their composition on the bioavailability of antiretroviral self-emulsifying formulations

References

• Akhila JS, Deepa S, Alwar MC. (2007). Acute toxicity studies and determination of median lethal dose. Curr Sci 93:917–20
   Web of Science ®Google Scholar
• Araya H, Tomita M, Hayashi M. (2006). The novel formulation design of self-emulsifying drug delivery systems (SEDDS) type o/w microemulsion III: the permeation mechanism of a poorly water soluble drug entrapped o/w microemulsion in rat isolated intestinal membrane by the Ussing chamber method. Drug Metab Pharmacokinet 21:45–53
   PubMed Web of Science ®Google Scholar
• Benghuzzi H. (2000). Long term sustained delivery of 3'-azido-2',3'-dideoxy thymidine in vivo by means of HA and TCP delivery devices. Biomed Sci Instrum 36:343–8
   PubMedGoogle Scholar
• Betagiri GV, Deshmukh DV, Gupta RB. (2001). Oral sustained- release bioadhesive tablet formulation of didanosine. Drug Dev Ind Pharm 27:129–36
   PubMed Web of Science ®Google Scholar
• Carvajal O, Nakayama M, Kishi T, et al. (2000). Effect of medium-chain fatty acid positional distribution in dietary triazcylglycerol on lymphatic lipid transport and chylomicron composition in rats. Lipid 35:1345–51
   PubMed Web of Science ®Google Scholar
• Charman SA, Charman WN, Rogge MC, et al. (1992). Self-emulsifying drug delivery systems: formulation and biopharmaceutics evaluation of an investigational lipophilic co mpound. Pharm Res 9:87–93
   PubMed Web of Science ®Google Scholar
• Charman WN, Porter CJH, Mithani S, Dressman JB. (1997). Physicochemical and physiological mechanism for the effects of food on drug absorption: the role of lipids and pH. J Pharm Sci 86:269–82
   PubMed Web of Science ®Google Scholar
• Chattopadhyay N, Zastre J, Wong HL, et al. (2008). Solid lipid nanoparticle enhance the delivery of the HIV protease inhibitor, atazanavir, by a human brain endothelial cell line. Pharm Res 25:2262–71
   PubMed Web of Science ®Google Scholar
• Constantinides PP. (1995). Lipid microemulsions for improving drug dissolution and oral absorption: physical and biopharmaceutical aspects. Pharm Res 12:1561–72
   PubMed Web of Science ®Google Scholar
• Craig CB, Darnell BE, Weinsier RL, et al. (1997). Decreased fat and nitrogen losses in patients with AIDS receiving medium-chain-triglyceride-enriched formula versus those receiving long-chain-triglyceride-containing formula. J Am Diet Assoc 97:605–11
   PubMed Web of Science ®Google Scholar
• Dahan A, Hoffman A. (2008). Rationalizing the selection of oral lipid based drug delivery systems by an in vitro dynamic lipolysis model for improved oral bioavailability of poorly water soluble drugs. J Control Release 129:1–10
   PubMed Web of Science ®Google Scholar
• Date AA, Nagarsenker MS. (2007). Design and evaluation of self-nanoemulsifying drug delivery systems (SNEDDS) for cefpodoxime proxetil. Int J Pharm 329:166–72
   PubMed Web of Science ®Google Scholar
• Desormeaux A, Bergeron MG. (1998). Liposome as drug delivery system: a strategic approach for the treatment of HIV infection. J Drug target 6:1–15
   PubMed Web of Science ®Google Scholar
• Devi KV, Pai RS. (2006). Antiretrovirals: need for an effective drug delivery. Indian J Pharm Sci 68:1–6
   Google Scholar
• Dixit AR, Rajput SJ, Patel SG. (2010). Preparation and bioavailability assessment of SMEDDS containing Valsartan. AAPS Pharm Sci Tech 11:314–21
   PubMed Web of Science ®Google Scholar
• Djordjevic L, Primorac M, Stupar M, Krajisnik D. (2004). Characterization of caprylocaproyl macrogolglycerides based microemulsion drug delivery vehicles for an amphiphilic drug. Int J Pharm 271:11–19
   PubMed Web of Science ®Google Scholar
• Dutta T, Agashe HB, Garg M, et al. (2007). Poly(propyleneimine) dendrimer based nanocontainers for targeting of efavirenz to human monocyte/macrophage, in vitro. J Drug Target 15:89–98
   PubMed Web of Science ®Google Scholar
• Eerdenburgh BV, Froyen L, Martens JA, et al. (2007). Characterization of physiochemical properties and pharmaceuticals performance of sucrose co-freeze dried solid nanoparticulate powder of the anti-HIV agent loviride prepared by media milling. Int J Pharm 338:198–206
   PubMedGoogle Scholar
• Gharzouli K, Senator A, Gharzouli A, et al. (1995). Acid secretion and fluoride absorption by the ligated stomach of the rat-mutual influences of fluoride and luminal acidity. Fluor 28:3–9
   Web of Science ®Google Scholar
• Ghosh PK, Majithiya RJ, Umrethia ML, Murthy RSR. (2006). Design and development of microemulsion drug delivery system of Acyclovir for improvement of oral bioavailability. AAPS PharmSciTech 7(3):E1--E6. Article 77. DOI: 10.1208/pt070377
   Google Scholar
• Govender S, Pillay V, Chetty DJ, et al. (2005). Optimisation and characterization of bioadhesive controlled release tetracycline microspheres. Int J Pharm 306:24–40
   Google Scholar
• Green PHR, Glickman RM. (1981). Intestinal lipoprotein metabolism. J Lipid Res 22:1153–73
   PubMed Web of Science ®Google Scholar
• Griffin BT, Driscoll CMO. (2006). A comparison of intestinal lymphatic transport and systemic bioavailability of saquinavir from three lipid based formulation in the anaesthetized rat model. J Pharm Pharmacol 58:917–25
   PubMed Web of Science ®Google Scholar
• Han KS, Lee MG. (1999). Effect of a new chemoprotective agent, 2-(allylthio)pyrazine, on the pharmacokinetics of intravenous theophylline in rats. Int J Pharm 184:237–42
   PubMedGoogle Scholar
• Hawi A, Bell G. (1994). Preformulation studies of nevirapine, a reverse transcriptase inhibitor. Pharm Res 11(Suppl):S236
   Google Scholar
• Hollanders RMF, Van Ewijk-Beneken Kolmer EWJ, et al. (2000). Determination of nevirapine, an HIV-1 non-nuceloside reverse transcriptase inhibitor, in human plasma by reversed-phase high-performance liquid chromatography. J Chromatogr B 744:65–71
   PubMed Web of Science ®Google Scholar
• Holm R, Porter CJH, Mullertz A, et al. (2002). Structured triglyceride vehicles for oral delivery of halofantrine: examination of intestinal lymphatic transport and bioavailability in conscious rats. Pharm Res 19:1354–61
   PubMed Web of Science ®Google Scholar
• Humberstone AJ, Charman WN. (1997). Lipid-based vehicles for the oral delivery of poorly water soluble drugs. Adv Drug Deliv Rev 25:103–28
   Web of Science ®Google Scholar
• Hung CR, Neu SL. (1997). Acid-induced gastric damage in rats is aggravated by starvation and prevented by several nutrients. J Nutr 127:630–6
   PubMed Web of Science ®Google Scholar
• ICH (Q1A (R2) harmonized tripartite guideline, stability testing of new drug substances and products Q1A (R2). Available from: http://www.ich.org/products/guidelines/quality/article/quality-guidelines.html [last accessed 12 Oct 2013]
   Google Scholar
• ICH Q2(B) (2003). Guidelines: validation of analytical procedure: methodology Q2(B), 2003. Available from: http://www.ich.org/products/guidelines/quality/article/quality-guidelines.html [last accessed 12 Oct 2013]
   Google Scholar
• Ikeda I, Tomari Y, Sugano M, et al. (1991). Lymphatic absorption of structured glycerolipids containing medium-chain fatty acids and linoleic acid, and their effect on cholesterol absorption in rats. Lipid 26:369–73
   PubMed Web of Science ®Google Scholar
• Jin SX, Wang DZJ, Wang YZ, et al. (2005). Pharmacokinetic and tissue distribution of zidovudine in rats following intravenous administration of zidovudine myristate loaded liposomes. Pharmazie 60:840–3
   PubMed Web of Science ®Google Scholar
• Kabra V, Agrahari V, Karthikeyan C, Trivedi P. (2009). Simulataneous quantitative determination of zidovudine and nevirapine in human plasma using isocratic, reverse phase high performance liquid chromatography. Trop J Pharm Res 8:79–86
   Web of Science ®Google Scholar
• Kang BK, Lee JS, Chon SK, et al. (2004). Development of self-microemulsifying drug delivery systems (SMEDDS) for oral bioavailability enhancement of simvastatin in beagle dogs. Int J Pharm 274:65–73
   PubMed Web of Science ®Google Scholar
• Kasim NA, Whitehouse M, Ramachandran C, et al. (2004). Molecular properties of WHO essential drugs and provisional. Mol Pharm 1:85–96
   PubMed Web of Science ®Google Scholar
• Kaur A, Jain S, Tiwary AK. (2008). Mannan-coated gelatine nanoparticles for sustained and targeted delivery of didanosine for site specific delivery. Acta Pharma 58:61–74
   PubMed Web of Science ®Google Scholar
• Kinman L, Brodie SJ, Tsai CC, et al. (2003). Lipid drug association enhanced HIV-1 protease inhibitor indinavir localization in lymphoid tissue and viral load reduction: a proof of concept study in HIV-22870-infected macaques. J Acquir Imm Def Synd 34:387–97
   PubMed Web of Science ®Google Scholar
• Kuo YC, Su SL. (2007). Transport of stavudine on polybutylcyanoacrylate and methyacrylate-sulfopropylmethacrylate and solid lipid nanoparticle. Int J Pharm 340:143–52
   PubMed Web of Science ®Google Scholar
• Lamson MJ, Sabo JP, MacGregor TR, et al. (1995). Single dose pharmacokinetics and bioavailability of nevirapine in healthy volunteers. Biopharm Drug Dispos 20:285–91
   Google Scholar
• Lee YH, Ku YS. (1999). Effects of cyclosporine on the pharmacokinetics of proparanolol after intravenous and oral administration to control rats and to rats with uranyl nitrate-induced acute renal failure. J Pharm Pharmacol 51:1149–54
   PubMed Web of Science ®Google Scholar
• Mainardes RM, Gremiao GP, Brunetti IL, et al. (2009). Zidovudine loaded PLA and PLA-PEG blend nanoparticle: influence of polymer type on phagocytic uptake by polymorphonuclear cells. J Pharm Sci 98:257–67
   PubMed Web of Science ®Google Scholar
• Makabi-Panzu B, Gourde P, Desormeaux A, Bergeron MG. (1998). Intracellular and serum stability of liposomal 2, 3'-deoxycytidine, effect of lipid composition. Cell Mol Bio 44:277–84
   Web of Science ®Google Scholar
• Mandloi DK, Rai VK, Dey S, et al. (2009). Method development and validation of RP-HPLC method in the detection of nevirapine in bulk drug and tablet formulation and application in in vitro dissolution study. J Global Pharm Tech 1:54–61
   Google Scholar
• Merck Index. (2006). An encyclopedia of chemicals, drugs and biological. In: Budavari S, O'Neal MJ, Smith A, et al. eds. 14th ed. USA: Merck & Co. Inc., Monograph Number 6514. pp. 1123
   Google Scholar
• Ministry of Environment & Forests (Animal Welfare Division), Government of India. (2007). Guidelines on the regulation of scientific experiments on animals: 9–141
   Google Scholar
• Minizi OMS, Ngaimisi E. (2010). Bioanalytical method for determination of nevirapine in-vivo in resource constrained laboratories. J Chem Pharm Res 2:431–9
   Google Scholar
• Mu H, Hoy CE. (2001). Intestinal absorption of specific structured triacylglycerols. J Lipid Res 42:792–8
   PubMed Web of Science ®Google Scholar
• Paget GE, Barnes JM. (1964). Evaluation of drug activities. In: Pharmacometrics, Vol. I., Laurence DR, Bacharach AL, eds. London and New York: Academic Press, 50
   Google Scholar
• Patil P, Joshi P, Paradkar A. (2004). Effect of formulation variables on preparation and evaluation of gelled self-emulsifying drug delivery system (SEDDS) of ketoprofen. AAPS Pharm Sci Tech 5:1–8
   Google Scholar
• Perlman ME, Murdande SB, Gumkowski MJ, et al. (2008). Development of a self-emulsifying formulation that reduces the food effect for torcetrapib. Int J Pharm Sci 351:15–22
   PubMed Web of Science ®Google Scholar
• Porter CJ, Charman WN. (1997). Uptake of drugs into the intestinal lymphatics after oral administration. Adv Drug Deliv Rev 25:71–89
   Web of Science ®Google Scholar
• Pouton CW. (1985). Self-emulsifying drug delivery systems: assessment of the efficiency of emulsification. Int J Pharm 27:335–48
   Web of Science ®Google Scholar
• Pouton CW. (1997). Formulation of self-emulsifying drug delivery systems. Adv Drug Deliv Rev 25:47–58
   Web of Science ®Google Scholar
• Pouton CW. (2000). Lipid formulations for oral administration of drugs: non-emulsifying, self-emulsifying and self-microemulsifying drug delivery systems. Eur J Pharm Sci 11:93–8
   PubMed Web of Science ®Google Scholar
• Pouton CW. (2006). Formulation of poorly water-soluble drugs for oral administration: physicochemical and physiological issues and the lipid formulation classification system. Eur J Phar Sci 29:278–87
   PubMed Web of Science ®Google Scholar
• Ramana LN, Sethuraman S, Ranga U, Krishnan UM. (2010). Development of a liposomal nanodelivery system for nevirapine. J Biomed Sci 17:57. DOI: 10.1186/1423-0127-17-57
   PubMed Web of Science ®Google Scholar
• Rao RN, Shinde DD. (2009). Two-dimensional LC-MS/MS determination of antiretroviral drugs in rat serum and urine. J Pharm Biomed Anal 50:994–9
   PubMed Web of Science ®Google Scholar
• Sanganwar GP, Sathigari S, Babu RJ, Gupta RB. (2010). Simulataneous production and co-mixing of microparticles of nevirapine with excipients by supercritical antisolvent method for dissolution enhancement. Eur J Pharm Sci 39:164–74
   PubMed Web of Science ®Google Scholar
• Shah NH, Carvajal MT, Patel CI, et al. (1994). Self-emulsifying drug delivery systems (SEDDS) with polyglycolyzed glycerides for improving in vitro dissolution and oral absorption of lipophilic drugs. Int J Pharm 106:15–23
   Web of Science ®Google Scholar
• Shah RB, Khan MA. (2004). Regional permeability of Salmon calcitonin in isolated rat gastrointestinal tracts: transport mechanism using Caco-2 cell monolayer. APPS J 34:1–5
   Google Scholar
• Shegokar R, Jansch M, Singh KK, Muller RH. (2011). In vitro protein adsorption studies on nevirapine nanosuspensions for HIV/AIDS chemotherapy. Nanomed 7:333–40
   PubMed Web of Science ®Google Scholar
• Shegokar R, Singh KK. (2011). Nevirapine nanosuspensions for HIV reservoir targeting. Pharmaz 66:408–15
   PubMed Web of Science ®Google Scholar
• Sun M, Zhai X, Xue K, et al. (2011). Intestinal absorption and intestinal lymphatic transport of sirolimus from self-microemulsifying drug delivery systems assessed using the single-pass intestinal perfusion (SPIP) technique and a chylomicron flow blocking approach: linear correlation with oral bioavailabilities in rats. Eur J Pharm Sci 43:132–40
   PubMed Web of Science ®Google Scholar
• United States Pharmacopoeia, 36/NF31. (2014). US Pharmacopoeial Convention, Rockville, MD, 1:807
   Google Scholar
• Wakerly MG, Pouton CW, Meakin BJ. (1987). Evaluation of the self emulsifying performance of a non-ionic surfactant-vegetable oil mixture. J Pharm Pharmacol 39:6
   Google Scholar
• Wanke CA, Pleskow D, Degirolami PC, et al. (1996). A medium chain triglyceride-based diet in patients with HIV and chronic diarrhoea reduces diarrhoea and malabsorption: a prospective, controlled trial. Nutri 12:766–71
   Google Scholar
• Waters L, John L, Nelson M. (2007). Non-nucleoside reverse transcriptase inhibitors: a review. Int J Clin Pract 61:105–18
   PubMed Web of Science ®Google Scholar
• Yang J-T, Kuo Y-C, Chung J-F. (2011). Human serum albumin-grafted cationic solid lipid nanoparticles for delivery of nevirapine in vivo. Int Conf Biosci Biochem Bioinfo 11:66–70
   Google Scholar